Shishiba Y, Ozawa Y, Ohtsuki N, Shimizu T
J Clin Endocrinol Metab. 1982 Apr;54(4):858-62. doi: 10.1210/jcem-54-4-858.
TSH receptor binding-inhibiting (TBI) and thyroid-stimulating (TSI) activities of Graves' immunoglobulin Gs (IgGs) were measured using the murine TSH receptor (mTBI) and the McKenzie LATS bioassay. In contrast to the expectation that only the IgGs positive for LATS showed mTBI activity, mTBI activity was closely correlated with TBI activity measured at the human TSH receptor regardless of LATS potency (r = 0.79; P less than 0.01), indicating a lack of species specificity of IgG in this particular aspect. In 7 to 15 IgGs positive for both mTBI and LATS, there was a significant correlation between the 2 parameters (r = -0.89; P less than 0.01). However, 4 IgGs among the 15 were positive for mTBI but negative for LATS even when tested at 3- to 7-fold concentrations of IgG.
使用鼠促甲状腺激素受体(mTBI)和麦肯齐长效甲状腺刺激素生物测定法测量格雷夫斯病免疫球蛋白G(IgG)的促甲状腺激素受体结合抑制(TBI)和促甲状腺(TSI)活性。与仅LATS阳性的IgG显示mTBI活性的预期相反,无论LATS效力如何,mTBI活性与在人促甲状腺激素受体处测量的TBI活性密切相关(r = 0.79;P小于0.01),表明在这一特定方面IgG缺乏物种特异性。在7至15种mTBI和LATS均为阳性的IgG中,这两个参数之间存在显著相关性(r = -0.89;P小于0.01)。然而,15种IgG中有4种即使在3至7倍IgG浓度下进行测试,mTBI为阳性但LATS为阴性。